PEEP Resuscitation Trial
- Conditions
- Newborn Resuscitation
- Interventions
- Device: Upright Resuscitator with PEEPDevice: Upright Resuscitator
- Registration Number
- NCT02971553
- Lead Sponsor
- Helse Stavanger HF
- Brief Summary
Each year, almost 3 million newborn babies die within their first month of life, often as a consequence of labour complications. Approximately 5% of newborns will not start breathing at birth and need immediate help. The optimal ventilation strategy with liquid-filled lungs has not been determined. Animal studies suggest that assisted ventilation with positive end expiratory pressure (PEEP) improves the aeration of liquid-filled lungs leading to more rapid recovery. However, no large human clinical studies have investigated the clinical responses to assisted ventilation with PEEP in asphyxiated newborns.
- Detailed Description
Laerdal Global Health has developed a PEEP valve which has been tested and shown to provide reliable end-expiratory pressures in a manikin model, even with a high mask leak. Whether this PEEP valve provides reliable PEEP in vivo and whether this translates to clinical beneficial outcomes remains to be proven.
The aim is to study whether lung aeration can be improved by adding a device for positive end expiratory pressure (PEEP) to better distend the airways in neonates more than 28 weeks gestation.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 330
- Neonates who need assisted bag/mask ventilation after birth due to failure to initiate breathing the first 60 seconds after birth.
- Babies with major deformities not deemed to be viable.
- Missing parental consent
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Upright Resuscitator with PEEP Upright Resuscitator with PEEP Ventilation with the Upright Resuscitator with PEEP Upright Resuscitator Upright Resuscitator Ventilation with the Upright Resuscitator (without PEEP)
- Primary Outcome Measures
Name Time Method Delta heart rate (beats/minute) during each ventilation sequence 10 minutes
- Secondary Outcome Measures
Name Time Method Neonatal outcome dead versus alive Up to 24 hours Time to cessation of ventilation Up to 1 hour Time to heart rate above 140 beats/minute Up to 1 hour Mean ariway pressures given Up to 1 hour Time to detection of exhaled CO2 above 1% and 4% Up to 1 hour
Trial Locations
- Locations (1)
Haydom Lutheran Hospital, Research Institute
🇹🇿Haydom, Manyara, Tanzania